Search research articles
Contact Us
Filters
Showing results (211-220 of 229) with videos related to
Page
of 23
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2025
Dostarlimab and niraparib in primary advanced ovarian cancer
A-C Hardy-Bessard, E Pujade-Lauraine, R G Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2024
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial
P Harter, C Marth, M-A Mouret-Reynier, et al.
ESMO Open
|
June 10, 2025
Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer
S Nag, I Ray Coquard, S Gupta, et al.
Gynecologic Oncology
|
July 7, 2020
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network
F Derquin, A Floquet, A C Hardy-Bessard, et al.
ESMO Open
|
November 3, 2023
Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAF<sup>V600</sup>-mutated melanoma
J Y Blay, C Cropet, S Mansard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2019
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial
O Trédan, Q Wang, D Pissaloux, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
April 3, 2019
Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up)
V Lavoue, C Huchon, C Akladios, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
April 3, 2019
Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology
V Lavoue, C Huchon, C Akladios, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
March 26, 2019
Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa
V Lavoue, C Huchon, C Akladios, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
February 2, 2019
[Part II drafted from the short text of the French guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up)]
V Lavoué, C Huchon, C Akladios, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 229) with videos related to
Sort By:
Page
of 23
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2025
Dostarlimab and niraparib in primary advanced ovarian cancer
A-C Hardy-Bessard, E Pujade-Lauraine, R G Moore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 11, 2024
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial
P Harter, C Marth, M-A Mouret-Reynier, et al.
ESMO Open
|
June 10, 2025
Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer
S Nag, I Ray Coquard, S Gupta, et al.
Gynecologic Oncology
|
July 7, 2020
Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network
F Derquin, A Floquet, A C Hardy-Bessard, et al.
ESMO Open
|
November 3, 2023
Long term activity of vemurafenib in cancers with BRAF mutations: the ACSE basket study for advanced cancers other than BRAF<sup>V600</sup>-mutated melanoma
J Y Blay, C Cropet, S Mansard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 14, 2019
Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial
O Trédan, Q Wang, D Pissaloux, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
April 3, 2019
Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up)
V Lavoue, C Huchon, C Akladios, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
April 3, 2019
Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology
V Lavoue, C Huchon, C Akladios, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|
March 26, 2019
Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Short text of the French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa
V Lavoue, C Huchon, C Akladios, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
February 2, 2019
[Part II drafted from the short text of the French guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Systemic and intraperitoneal treatment, elderly, fertility preservation, follow-up)]
V Lavoué, C Huchon, C Akladios, et al.
Page
of 23